Eli Lilly Dealt Another Setback as Lung Cancer Drug Flunks Phase III Test Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Alex Keown, BioSpace.com Breaking… Source: BioSpace You Might Also Like Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub October 8, 2017 Social Media Rumors of Juno Acquisition Cause Stock Jitters January 24, 2017 Voyager Sinks as Sanofi Genzyme Opts Out of Parkinson's Gene Therapy Program October 30, 2017
